Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04403594 · ClinicalTrials.gov registry record

Functional Intermuscular Reduction of Spasticity

A clinical trial of Multiple Sclerosis, sponsored by University of Oklahoma.

Completed
Registry status
16
Enrollment target
1
Study location

NCT04403594: Completed study of Multiple Sclerosis, sponsored by University of Oklahoma.

NCT04403594 is a study of Multiple Sclerosis that has completed, run by University of Oklahoma. The registered enrollment target is 16 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04403594, a study of Multiple Sclerosis, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

Investigators will use muscular dry needling in the calf of one lower extremity, followed by treadmill training with functional electrical stimulation.

Primary Outcome

distance walked over 6 minutes assessed at the start of the study and after 6 weeks.

Conditions Studied

Interventions

  • OTHER dry needling

Study Locations (1)

Oklahoma

  • Oklahoma Medical Research Foundation - Oklahoma City

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2019-08-19
Est. Completion 2021-04-18
University of Oklahoma

358 total trials

What the finished NCT04403594 record still lists

NCT04403594 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which dry needling is the first listed.

NCT04403594 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT04403594 about?

NCT04403594 is a clinical study titled "Functional Intermuscular Reduction of Spasticity". Investigators will use muscular dry needling in the calf of one lower extremity, followed by treadmill training with functional electrical stimulation.

What is the current status of trial NCT04403594?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2019-08-19. Estimated completion is 2021-04-18.

What conditions does trial NCT04403594 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT04403594?

The interventions under investigation include: dry needling (OTHER).

Who is sponsoring clinical trial NCT04403594?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04403594 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04403594's enrollment target sits among peer trials

16 282nd of 315 higher than 33 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04403594, the US trial registry maintained by the National Library of Medicine. NCT04403594 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.